Search

Author/Creator Graham, J.D.

1. 19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476). Issue 3 (September 2015)

Authors:
James, N.D.; Sydes, M.R.; Mason, M.D.; Clarke, N.W.; Dearnaley, D.P.; Spears, M.R.; Millman, R.; Parker, C.C.; Ritchie, A.W.S.; Russell, J.M.; Staffurth, J.; Jones, R.J.; Cathomas, R.; Robinson, A.; Chowdhury, S.; Tsang, D.; Brock, S.; Parikh, O.; Graham, J.D.; Parmar, M.K.B.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 3(2015:Feb.)
Page Start:
S719
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search